Hemodialysis international. International Symposium on Home Hemodialysis · 2025
Practical Use of Continuous Glucose Monitoring to Adjust Glucose-Lowering Therapy in Hemodialysis Patients: A Case Series.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Meyer-Olesen Christine L, Christensen Merete B, Kofod Dea H, Hornum Mads, Nørgaard Kirsten, Bomholt Tobias
Аннотация
INTRODUCTION: Diabetes management in hemodialysis patients is complicated by limited treatment options and challenges in glycemic monitoring. Continuous glucose monitoring (CGM) provides detailed glucose profiles, enabling tailored glucose-lowering therapy.
METHODS: This case series presents three insulin-treated hemodialysis patients with type 1 or type 2 diabetes.
FINDINGS: Each case reveals significant glycemic abnormalities, including excessive hyperglycemia with nocturnal glucose drops, unrecognized hypoglycemia, and extreme glucose variability. We propose specific personalized insulin adjustments based on CGM readings to optimize treatment across these different clinical scenarios.
CONCLUSIONS: The case series highlights the potential to rethink glucose monitoring in hemodialysis patients with diabetes and underlines the need for future studies evaluating CGM use in this population.
METHODS: This case series presents three insulin-treated hemodialysis patients with type 1 or type 2 diabetes.
FINDINGS: Each case reveals significant glycemic abnormalities, including excessive hyperglycemia with nocturnal glucose drops, unrecognized hypoglycemia, and extreme glucose variability. We propose specific personalized insulin adjustments based on CGM readings to optimize treatment across these different clinical scenarios.
CONCLUSIONS: The case series highlights the potential to rethink glucose monitoring in hemodialysis patients with diabetes and underlines the need for future studies evaluating CGM use in this population.